Page last updated: 2024-08-21

alpha-aminopyridine and Neoplasms, Cystic, Mucinous, and Serous

alpha-aminopyridine has been researched along with Neoplasms, Cystic, Mucinous, and Serous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, XL; Jean, C; Lawson, C; Miller, NL; Schlaepfer, DD; Shah, NR; Sulzmaier, FJ; Tancioni, I; Uryu, S; Ward, KK	1

Other Studies

1 other study(ies) available for alpha-aminopyridine and Neoplasms, Cystic, Mucinous, and Serous

Article	Year
FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth. Molecular cancer therapeutics, 2014, Volume: 13, Issue:8 Topics: Aminopyridines; Animals; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Focal Adhesion Kinase 1; Gene Knockdown Techniques; Humans; Integrin beta Chains; Kaplan-Meier Estimate; Mice, Nude; Neoplasm Transplantation; Neoplasms, Cystic, Mucinous, and Serous; Osteopontin; Ovarian Neoplasms; Signal Transduction	2014

Article

Year

FAK Inhibition disrupts a β5 integrin signaling axis controlling anchorage-independent ovarian carcinoma growth.

Molecular cancer therapeutics, 2014, Volume: 13, Issue:8

Topics: Aminopyridines; Animals; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Female; Focal Adhesion Kinase 1; Gene Knockdown Techniques; Humans; Integrin beta Chains; Kaplan-Meier Estimate; Mice, Nude; Neoplasm Transplantation; Neoplasms, Cystic, Mucinous, and Serous; Osteopontin; Ovarian Neoplasms; Signal Transduction

2014